 |
| Opinion |  Top |
|
 |
|
| Editorials |
|
|
|
Public information, private money p491
doi:10.1038/nbt0698-491a
PDF
(144K)
|
|
|
|
Keep the story straight p491
doi:10.1038/nbt0698-491b
PDF
(143K)
|
|
 |
|
| Commentary |
|
|
|
Why pharmacogenomics? Why now? pp492 - 493
David Housman
& Fred D. Ledley
doi:10.1038/nbt0698-492
References | PDF
(326K)
|
|
|
|
Transferring EU-funded biotechnology research to European bioindustry p494
Colm Lawler, Robert van der Meer
& Jacques Viseur
doi:10.1038/nbt0698-494
References | PDF
(178K)
|
|
|
|
Do corporate gifts compromise biotech researchers? p495
Russ Hoyle
doi:10.1038/nbt0698-495
PDF
(143K)
|
|
|
|
| Correspondence |
|
|
|
deCODE deferred p496
Jorunn Erla Eyfjörd, Helga M. Ögmundsdottir
& Tomas Zoëga
doi:10.1038/nbt0698-496a
References | PDF
(269K)
|
|
|
|
Unfair treatment p496
John Fowlkes
doi:10.1038/nbt0698-496b
References | PDF
(270K)
|
|
|
|
Gene therapy or antisense p496
Vittorio Tomasi
doi:10.1038/nbt0698-496c
References | PDF
(270K)
|
|
| In Brief | Top |
|
|
|
| Business and Regulatory News |
|
|
|
Business and Regulatory News pp497 - 499
doi:10.1038/nbt0698-497
PDF
(686K)
|
|
|
|
| Research News |
|
|
|
Research News p500
doi:10.1038/nbt0698-500
PDF
(247K)
|
|
|
|
| This Month in Biotechnology |
|
|
|
This Month in Nature Biotechnology p501
doi:10.1038/nbt0698-501
PDF
(259K)
|
|
| Analysis | Top |
|
|
|
| Business and Regulatory News |
|
|
|
Net to help catch NZ serum forgers p503
John Hodgson
doi:10.1038/nbt0698-503a
PDF
(144K)
|
|
|
|
British Biotech taints British biotech pp503 - 504
Adam Michael
doi:10.1038/nbt0698-503b
PDF
(271K)
|
|
|
|
E&Y notes shift in new BT activity pp504 - 505
Vicki Glaser
doi:10.1038/nbt0698-504
PDF
(450K)
|
|
|
|
US officials clash with industry executives over BWC p506
Jeffrey L. Fox
doi:10.1038/nbt0698-506a
PDF
(164K)
|
|
|
|
Drug bill cuts force firms overseas pp506 - 507
Asako Saegusa
doi:10.1038/nbt0698-506b
PDF
(392K)
|
|
|
|
BMS cancer spin-off raises first finance p508
Vicki Brower
doi:10.1038/nbt0698-508a
PDF
(289K)
|
|
|
|
From Genetic Systems to Seattle Genetics p508
Vicki Brower
doi:10.1038/nbt0698-508b
PDF
(289K)
|
|
|
|
Chips advance but cost constraints remain p509
Debra Robertson
doi:10.1038/nbt0698-509
PDF
(182K)
|
|
|
|
Central criminal DNA database created in Germany pp510 - 511
Ellen Peerenboom
doi:10.1038/nbt0698-510
PDF
(386K)
|
|
|
|
Researcher and Amgen baffled by Love letter p511
Alan Dove
doi:10.1038/nbt0698-511
PDF
(185K)
|
|
|
|
| Research News |
|
|
|
Revolution on a square centimeter pp513 - 514
Larry J. Kricka
doi:10.1038/nbt0698-513
References | PDF
(294K)
|
|
|
|
Shining a light on protein sociobiology pp514 - 515
Richard N. Day
doi:10.1038/nbt0698-514
References | PDF
(375K)
|
|
|
|
The ins and outs of on and off p516
Robert M. Sapolsky, Dora Y. Ho
& John McLaughlin
doi:10.1038/nbt0698-516
References | PDF
(127K)
|
|
|
|
DNA vaccines with a kick pp517 - 518
John M. Polo
& Thomas W. Dubensky Jr.
doi:10.1038/nbt0698-517
References | PDF
(485K)
|
|
|
|
Gene knockouts galore pp519 - 520
Raju Kucherlapati
doi:10.1038/nbt0698-519
References | PDF
(444K)
|
|
|
|
Postgenomic protein analysis: The next bend in the river pp520 - 521
Andrew R. Mendelsohn
& Roger Brent
doi:10.1038/nbt0698-520
References | PDF
(348K)
|
|
| Features | Top |
|
|
|
Questions from a scientific audience: How do I get started? pp522 - 524
Charles M. Cohen, Rachel Leheny
& Doros Platika
doi:10.1038/nbt0698-522
PDF
(935K)
|
|
|
|
Valuing biotechnology assets pp525 - 529
Todd R. Nelson
& Arijit Mukherji
doi:10.1038/nbt0698-525
References | PDF
(1,119K)
|
|
|
|
The insects are coming pp530 - 533
Andrew Marshall
doi:10.1038/nbt0698-530
References | PDF
(1,489K)
|
|
| Research Review | Top |
|
|
|
Human antibodies by design pp535 - 539
Tristan J. Vaughan, Jane K. Osbourn
& Philip R. Tempest
doi:10.1038/nbt0698-535
Abstract + references | PDF
(824K)
|
|
| Research Articles | Top |
|
|
|
Preparation and hybridization analysis of DNA/RNA from E. coli on microfabricated bioelectronic chips pp541 - 546
Jing Cheng, Edward L. Sheldon, Lei Wu, Adam Uribe, Louis O. Gerrue, John Carrino, Michael J. Heller
& James P. O'Connell
doi:10.1038/nbt0698-541
Abstract + references | PDF
(906K)
|
|
|
|
Bcl-2 and Bax interactions in mitochondria probed with green fluorescent protein and fluorescence resonance energy transfer pp547 - 552
Nupam P. Mahajan, Katrina Linder, Gail Berry, Gerald W. Gordon, Roger Heim
& Brian Herman
doi:10.1038/nbt0698-547
Abstract + references | PDF
(1,018K)
|
|
|
|
Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system pp553 - 555
Thomas C. Harding, Brad J. Geddes, David Murphy, David Knight
& James B. Uney
doi:10.1038/nbt0698-553
Abstract + references | PDF
(517K)
|
|
|
|
A nuclease-resistant protein kinase C ribozyme blocks glioma cell growth pp556 - 561
Mouldy Sioud
& Dag R. Sørensen
doi:10.1038/nbt0698-556
Abstract + references | PDF
(1,015K)
|
|
|
|
Enhancing immune responses using suicidal DNA vaccines pp562 - 565
Peter Berglund, Cristian Smerdou, Marina N. Fleeton, loannis Tubulekas
& Peter Liljeström
doi:10.1038/nbt0698-562
Abstract + references | PDF
(1,227K)
|
|
|
|
Quantitative whole-genome analysis of DNA-protein interactions by in vivo methylase protection in E. coli pp566 - 571
Saeed Tavazoie
& George M. Church
doi:10.1038/nbt0698-566
Abstract + references | PDF
(951K)
|
|
|
|
An integrated microbial process for the bioremediation of soil contaminated with toxic metals pp572 - 575
Christopher White, Ajay K. Shaman
& Geoffrey M. Gadd
doi:10.1038/nbt0698-572
Abstract + references | PDF
(446K)
|
|
|
|
Surface display of Zymomonas mobilis levansucrase by using the ice-nucleation protein of Pseudomonas syringae pp576 - 580
Heung-Chae Jung, Jean-Michel Lebeault
& Jae-Gu Pan
doi:10.1038/nbt0698-576
Abstract + references | PDF
(757K)
|
|
|
|
Cloning of cell-specific secreted and surface proteins by subtractive antibody screening pp581 - 586
Philipp E. Scherer, Perry E. Bickel, Mariana Kotler
& Harvey F. Lodish
doi:10.1038/nbt0698-581
Abstract + references | PDF
(937K)
|
|
| Resources | Top |
|
|
|
| Patents |
|
|
|
When failing to offer your best mode leads to antitrust pp587 - 588
Breffni Baggot
doi:10.1038/nbt0698-587
References | PDF
(355K)
|
|
|
|
Recent patent applications in transgenics p589
doi:10.1038/nbt0698-589
PDF
(807K)
|
|
|
|
| WWW Guide |
|
|
|
Websites for the business of biotechnology p590
Michael Francisco
doi:10.1038/nbt0698-590
PDF
(602K)
|
|
|
|
| New Products |
|
|
|
Antibodies p591
doi:10.1038/nbt0698-591
PDF
(261K)
|
|
|
|
| People |
|
|
|
People p592
doi:10.1038/nbt0698-592
PDF
(384K)
|
|
|
|
| Industry Trends |
|
|
|
Extremophiles pp593 - 594
Aris Persidis
doi:10.1038/nbt0698-593
References | PDF
(547K)
|
|
|
Top |
|
|
